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Letters to the EditorENDOCARDITIS SURGERY:
NEED FOR A SPECIFIC RISK
SCORING SYSTEM
To the Editor:
The study by Gaca and colleagues,1
reporting on the outcomes of infective
endocarditis (IE) surgery in a selected
portion of the Society of Thoracic Sur-
geons (STS) database population, de-
serves to be praised for representing
the first attempt in the literature to de-
velop a system for operative risk as-
sessment specific for endocarditis.
The need for a dedicated stratifica-
tion tool, useful both in preoperative
patient information and in bedside
decision-making processes, arises
from the peculiarities of IE surgery
compared with general cardiac sur-
gery: Postoperative outcomes may be
influenced not only by cardiovascular
anatomic and functional issues but
also by systemic infective and micro-
biological factors. One fundamental
variable affecting surgical outcome
is whether a native or prosthetic valve
is involved,2 mostly because of the
differential preoperative risk profiles
between these 2 distinct diseases.3 It
is unfortunate that the STS database
does not distinguish between native
and prosthetic IE; thus, this variable
was not considered when developing
the proposed score system.1 Other
factors pertaining to the infectious
process, including the anatomic pic-
ture (presence/absence of vegetations,
perivalvular abscess, or mycotic aneu-
rysms) and the microbiological cause,
are demonstrated to independently
predict outcomes.4 In addition, these
factors were lacking in the regression
models of the Duke study.1
Consequently, the proposed risk
score systems were formed by 13
and 14 risk factors for mortality and
composite end point, respectively,
that are generic; ‘‘active endocarditis’’
was the sole specific variable in-
cluded. Indeed, Gaca and colleagues’
system1 results in being a simplifica-
tion of the ‘‘valvular’’ STS score sys-
tem and substantially differs from theThe JournalEuropean System for Cardiac Opera-
tive Risk Evaluation, the other most
widely used tool, for only 3 factors,
but not specific for infective valve
disease. Both the authors’ score,1 al-
though with a C-statistic indicating
modest discriminating power, and
the European System for Cardiac Op-
erative Risk Evaluation, as recently
reported by others,5 consistently dem-
onstrated satisfactory performances in
IE prognostic stratification.
We are currently at work on a spe-
cific system for preoperative prognos-
tic stratification of native valve IE,
accounting, in multivariable analyses,
also for infective and anatomic vari-
ables. Our preliminary studies (M.
De Feo, MD, PhD, unpublished data,
2011) yielded a score system in which
critical preoperative hemodynamic
condition and renal failure were
among the most important predictors
of death. As Gaca and coworkers1 out-
lined, this is consistent with other ge-
neric cardiac surgery risk models.
However, 2 of the 6 risk factors ulti-
mately constituting our score system
were specific for the IE setting, that is,
perivalvular involvement and positivity
of the last preoperative blood culture
(that indicates unsuccessful or incom-
plete antibiotic therapy), a variable
significantly associated, in bivariate
analysis, with positive valve culture,
staphylococcal cause, emergency oper-
ation, and large vegetations.
The authoritativeness of the
authors’ institution in this field is
undoubted, and their previous contri-
butions to the knowledge on endocar-
ditis have set the benchmark for us all
in the daily clinical approach to this
high-risk disease. However, compared
with the importance and timeliness of
the study purpose, the limitations
affecting the regression models under-
lying Gaca and colleagues’ score1
constituted an important flaw.
Alessandro Della Corte, MD, PhDa
Maurizio Cotrufo, MDa,b
Antonio Carozza, MD, PhDa
aDepartment of Cardiothoracicof Thoracic and Cardiovascular SurgeSciences
Second University of Naples
V. Monaldi Hospital
Naples, Italy
bDepartment of Cardiovascular
Surgery
‘‘Pineta Grande’’ Hospital
Castelvolturno (CE), ItalyReferences
1. Gaca JG, Sheng S, Daneshmand MA, O’Brien S,
Rankin JS, Brennan JM, et al. Outcomes for endo-
carditis surgery in North America: a simplified risk
scoring system. J Thorac Cardiovasc Surg. 2011;
141:98-106.e1-2.
2. Aranki SF, Santini F, Adams DH, Rizzo RJ,
Couper GS, Kinchla NM, et al. Aortic valve endo-
carditis. Determinants of early survival and late
morbidity. Circulation. 1994;90:II175-82.
3. Romano G, Carozza A, Della Corte A, De
Santo LS, Amarelli C, Torella M, et al. Native
versus primary prosthetic valve endocarditis:
comparison of clinical features and long-term out-
come in 353 patients. J Heart Valve Dis. 2004;13:
200-8.
4. Galvez-Acebal J, Rodrıguez-Ba~no J, Martınez-
Marcos FJ, Reguera JM, Plata A, Ruiz J, et al.,
Grupo para el Estudio de las Infecciones Cardio-
vasculares de la Sociedad Andaluza de Enferme-
dades Infecciosas (SAEI). Prognostic factors in
left-sided endocarditis: results from the Andalu-
sian multicenter cohort. BMC Infect Dis. 2010;
10:17.
5. Mestres CA, Castro MA, Bernabeu E, Josa M,
Cartana R, Pomar JL, et al., Hospital Clınico
Endocarditis Study Group. Preoperative risk strati-
fication in infective endocarditis. Does the Euro-
SCORE model work? Preliminary results. Eur
J Cardiothorac Surg. 2007;32:281-5.
doi:10.1016/j.jtcvs.2011.02.049LATE POSTOPERATIVE
PERICARDIAL EFFUSION
To the Editor:
We read with interest the article by
Inan and colleagues.1 They have come
up with a good double-blind study on
a poorly studied but potentially lethal
complication after cardiac surgery.
They state that postoperative pericar-
dial effusion is multifactorial; how-
ever, they have come up with one
magic bullet for all the factors. They
also fail to tell us the nature of the
drained fluid. They had a significant
number of patients with mechanical
aortic valves whowere treated by anti-
coagulation and are expected to havery c Volume 142, Number 3 721
TABLE 1. Patient and disease profiles
Age Diagnosis PAP TR Surgery INR Tamponade
Surgical management/
pericardiocentesis
34 MS/MR <60 Moderate MVR >7 þ Surgical drainage
38 MS/AR >60 Severe DVRþTV repair >7 þ Surgical drainage
40 MS/MR >60 Severe MVRþTV repair >7  Pericardiocentesis
40 MS/MR/AR >60 Severe DVRþTV repair >7  Pericardiocentesis
40 MS/MR >60 Mild MVR >7 þ Died
PAP, Pulmonary artery pressure; TR, tricuspid regurgitation; INR, international normalized ratio; MS, mitral stenosis; MR, mitral regurgitation; AR, aortic regurgitation; MVR,
mitral valve replacement; DVR, double valve replacement; TV, tricuspid valve.
Letters to the Editorhemorrhagic pericardial fluid. This
kind of pericardial effusion may not
be prevented by indomethacin. We
have seen 5 patients receiving antico-
agulants who had late (>7 days after
surgery) pericardial effusions over
the past year (Table 1). All these pa-
tients had hemorrhagic effusions and
high international normalized ratio
(INR) values. The pathophysiology
of effusions in these patients is not
very clearly understood. High peaks
in INR values causing prolonged ooz-
ing into the pericardial cavity is the
commonly accepted theory.2 We spec-
ulate with Wong and Pugsley3 that
congestion of the liver owing to right
heart failure or tamponade physiology
maybe the triggering factor for high
INR values in these patients. Most
patients in our experience had high
pulmonary artery pressures and tricus-
pid regurgitation of varying severity
(Table 1). Moreover, all the patients
are back on anticoagulant dosages
similar to their pretamponade dos-
ages, further supporting the fact that
transient liver dysfunction may have
a role in abrupt increase in INR in
the early postoperative period. We
use indomethacin in patients who
have a pericardial rub associated
with pain or electrocardiographic
changes suggestive of pericarditis;
this is restricted to 2 to 3 days. All pa-
tients are discharged when the INR is
greater than 1.7 and are reviewed
3 and 14 days after discharge. Indo-
methacin is a drug with many serious
side effects and its use should be se-
lective at best.
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We read the letter by Drs Theodore,
Christi, and Christopher. The main
point of the critics focuses on postop-
erative pericardial effusion; however,
they argue about the idea of the drug
for multiple purposes. One of the im-
portant properties of our article is the
population involved—patients under-
going aortic surgery.1 The patients
were carefully selected for this study,
and the article mainly stated the statis-
tically confirmed data, rather than car-
diac surgery experiences. Yes, there
were patients who underwent aortic
valve replacement besides aortic proce-
dures, who were receiving anti-
coagulants in the postoperative period.
However, these patients were more
closely followed up for regulation of
international normalized ratio thanardiovascular Surgery c September 201routine patients who are receiving
anticoagulants. The patients who
undergo valve replacement have dif-
ferent pathologic pathways for post-
operative pericardial effusion than
do patients who undergo aortic sur-
gery.2-4 In our study, the nature of
the postoperative pericardial effusion
fluid was serous, not hemorrhagic.
Likewise, the nature of drained fluid
during pericarditis is usually serous
in origin.
In the article we suggested that the
inflammatory process takes place af-
ter the aortic surgery, whether the pa-
tients receive anticoagulants or not.
This is a new prospect for an un-
solved problem, not a magic bullet
for all.
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